Science:3D打印器官很大难题—微小血管网络首被攻破

2019-05-19 美柏 健康界

1目前,我们几乎已经可以做到在实验室内自主培养人体器官,但如何创造出器官生长所需的血管网络——这一最大难关仍未被攻破。一项研究表明,只需一种常见的食物染料即可解决这一问题。在美国,目前有超过10万人仍在等待器官进行移植。即使你足够幸运,等到了匹配的器官并完成了移植,也将不得不终生服用免疫抑制剂。这就是为什么科学家们一直以来都梦想着能使用病人自己的细胞培养新的器官,这将同时解决器官资源短缺和器官排异

1

目前,我们几乎已经可以做到在实验室内自主培养人体器官,但如何创造出器官生长所需的血管网络——这一最大难关仍未被攻破。一项研究表明,只需一种常见的食物染料即可解决这一问题。

在美国,目前有超过10万人仍在等待器官进行移植。即使你足够幸运,等到了匹配的器官并完成了移植,也将不得不终生服用免疫抑制剂。这就是为什么科学家们一直以来都梦想着能使用病人自己的细胞培养新的器官,这将同时解决器官资源短缺和器官排异风险这两个问题。

这些年,组织工程学领域已经取得了很大的进展。实验室培养的人工皮肤应用于医学领域已有数十年历史。并且,无论是人工材料还是人体自然支撑结构中提取出的细胞制成的干细胞都已经被用于培养生物支架。

2

然而,最激动人心的进展是将3D打印技术引入该领域,这有望将工程师享受的速度、灵活性以及定制活动带入生物医学领域。

所谓的生物打印机已被用于制造用于科学研究的细胞器,并且已有令人信服的证据表明“制造完整的器官”这一概念很可能成真。

但是所有的组织工程师面临的共同挑战是如何形成血管网络。建造零散的组织并不难,但是科学家们一直在努力创造复杂的微小血管网络,这些血管可以将营养物质和氧气带入血管,同时将废物带出。这就是为什么大部分实验成果都是直径一两英寸或者中空的结构,例如喉咙或膀胱。

现在一支由美国莱斯大学科学家领导的研究团队已经创建出了一个3D生物打印机,它可以打印生物相容性水凝胶中不到三分之一毫米宽的血管。《科学》杂志刊出的文章,描述了他们是如何使用生物打印机创建出了一个可以有效地为人体血液供氧的人体肺部模型。

该团队使用了一种常见的被称为投影立体光刻(projection stereolithography)的3D打印技术,它使用光线逐层固化光敏树脂。

生成轻量级的高分辨率图案相当简单,但挑战在于如何使树脂足够敏感以复制那些微小的细节。一个关键的发现是一种名为“黄色5号”的常见食用染料,它可以有效地吸收蓝光,同时将凝固过程限制在一个非常精细的层次中。这种化学物质来自食品和饮料生产行业,因此是安全无毒的。

他们用这种方法创建了一个复杂的肺部模型,模型中细小的肺泡被完善的血管网络包裹着。实验中,他们发现人造器官可以为血液供氧。为了证明该技术有朝一日可以用于人类,他们还使用了打印出的组织载体,在将它们植入小鼠之前使其载入肝细胞。

3

莱斯大学的研究团队并不是唯一一支致力于攻克这一难题的团队。新成立的Prellis Biologics公司也致力于生物打印微小的毛细血管,去年12月,他们推出了一系列带有内置毛细血管的组织支架。

虽然解决血液供应问题一直是组织工程师的首要愿望,但最新研究的作者们指出,循环系统并不是唯一一个存在这些精细结构的地方。

“我们的器官实际上包含独立的血管网络——如肺部的气道和血管,或胆管和肝脏中的血管,”莱斯大学生物工程助理教授兼《科学》报告的高级作者Jordan Miller说。

“这些互相贯穿的网络在物理和生物化学领域互相联结,而体系结构本身与组织功能密切相关。我们运用的技术是第一个以直接且全面的方式应对多种血管挑战的生物打印技术,“他说。

要想将这种技术应用于打印整个器官,仍然任重道远,但这种方法克服了这一艰难过程中的一个主要障碍。值得注意的是,研究人员决定公开该项目,以便其他人能够以他们的设计为基础,加快推动该领域的发展。

参考资料:

https://singularityhub.com/2019/05/07/new-progress-in-the-biggest-challenge-with-3d-printed-organs/

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1234226, encodeId=f624123422614, content=<a href='/topic/show?id=714a1226f4' target=_blank style='color:#2F92EE;'>#3D打印#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1226, encryptionId=714a1226f4, topicName=3D打印)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Jul 23 12:30:53 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336120, encodeId=89f4133612068, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Tue May 21 10:59:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375939, encodeId=8dfe13e5939ac, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Tue May 21 10:59:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366499, encodeId=27ea3664998f, content=向挑战病魔的科研人员致敬!向挑战病魔的科研人员致敬!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Mon May 20 14:28:45 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366469, encodeId=6eaa366469e1, content=真好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Mon May 20 00:11:13 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366458, encodeId=e9ff366458a7, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Sun May 19 20:15:48 CST 2019, time=2019-05-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1234226, encodeId=f624123422614, content=<a href='/topic/show?id=714a1226f4' target=_blank style='color:#2F92EE;'>#3D打印#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1226, encryptionId=714a1226f4, topicName=3D打印)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Jul 23 12:30:53 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336120, encodeId=89f4133612068, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Tue May 21 10:59:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375939, encodeId=8dfe13e5939ac, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Tue May 21 10:59:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366499, encodeId=27ea3664998f, content=向挑战病魔的科研人员致敬!向挑战病魔的科研人员致敬!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Mon May 20 14:28:45 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366469, encodeId=6eaa366469e1, content=真好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Mon May 20 00:11:13 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366458, encodeId=e9ff366458a7, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Sun May 19 20:15:48 CST 2019, time=2019-05-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1234226, encodeId=f624123422614, content=<a href='/topic/show?id=714a1226f4' target=_blank style='color:#2F92EE;'>#3D打印#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1226, encryptionId=714a1226f4, topicName=3D打印)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Jul 23 12:30:53 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336120, encodeId=89f4133612068, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Tue May 21 10:59:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375939, encodeId=8dfe13e5939ac, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Tue May 21 10:59:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366499, encodeId=27ea3664998f, content=向挑战病魔的科研人员致敬!向挑战病魔的科研人员致敬!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Mon May 20 14:28:45 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366469, encodeId=6eaa366469e1, content=真好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Mon May 20 00:11:13 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366458, encodeId=e9ff366458a7, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Sun May 19 20:15:48 CST 2019, time=2019-05-19, status=1, ipAttribution=)]
    2019-05-21 jichang
  4. [GetPortalCommentsPageByObjectIdResponse(id=1234226, encodeId=f624123422614, content=<a href='/topic/show?id=714a1226f4' target=_blank style='color:#2F92EE;'>#3D打印#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1226, encryptionId=714a1226f4, topicName=3D打印)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Jul 23 12:30:53 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336120, encodeId=89f4133612068, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Tue May 21 10:59:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375939, encodeId=8dfe13e5939ac, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Tue May 21 10:59:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366499, encodeId=27ea3664998f, content=向挑战病魔的科研人员致敬!向挑战病魔的科研人员致敬!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Mon May 20 14:28:45 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366469, encodeId=6eaa366469e1, content=真好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Mon May 20 00:11:13 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366458, encodeId=e9ff366458a7, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Sun May 19 20:15:48 CST 2019, time=2019-05-19, status=1, ipAttribution=)]
    2019-05-20 坚强007

    向挑战病魔的科研人员致敬!向挑战病魔的科研人员致敬!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1234226, encodeId=f624123422614, content=<a href='/topic/show?id=714a1226f4' target=_blank style='color:#2F92EE;'>#3D打印#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1226, encryptionId=714a1226f4, topicName=3D打印)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Jul 23 12:30:53 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336120, encodeId=89f4133612068, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Tue May 21 10:59:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375939, encodeId=8dfe13e5939ac, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Tue May 21 10:59:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366499, encodeId=27ea3664998f, content=向挑战病魔的科研人员致敬!向挑战病魔的科研人员致敬!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Mon May 20 14:28:45 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366469, encodeId=6eaa366469e1, content=真好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Mon May 20 00:11:13 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366458, encodeId=e9ff366458a7, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Sun May 19 20:15:48 CST 2019, time=2019-05-19, status=1, ipAttribution=)]
    2019-05-20 smartxiuxiu

    真好!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1234226, encodeId=f624123422614, content=<a href='/topic/show?id=714a1226f4' target=_blank style='color:#2F92EE;'>#3D打印#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1226, encryptionId=714a1226f4, topicName=3D打印)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Jul 23 12:30:53 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336120, encodeId=89f4133612068, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Tue May 21 10:59:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375939, encodeId=8dfe13e5939ac, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Tue May 21 10:59:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366499, encodeId=27ea3664998f, content=向挑战病魔的科研人员致敬!向挑战病魔的科研人员致敬!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Mon May 20 14:28:45 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366469, encodeId=6eaa366469e1, content=真好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Mon May 20 00:11:13 CST 2019, time=2019-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366458, encodeId=e9ff366458a7, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Sun May 19 20:15:48 CST 2019, time=2019-05-19, status=1, ipAttribution=)]
    2019-05-19 329523732

    不错

    0

相关资讯

Adv Sci:突破!3D打印的“人造心脏”诞生,有望变革器官移植

今日,来自以色列特拉维夫大学的科学家们又给我们带来了一项突破。一支科研团队用人类的脂肪组织,通过一系列神奇的操作,最终成功3D打印出了一颗“人造心脏”。它虽然只是一个微缩版的原型,却是人类“首次成功设计并打印出一个具有细胞、血管、心室和心房的心脏”。这颗心脏可以说是生物学、材料学、计算机科学等诸多学科联合带来的科学突破。具体来看,研究人员们先从一些患者的体内取出了一些脂肪组织,然后将其“细胞”与“

3D打印技术在PaproskyⅢ型髋臼骨缺损翻修手术中应用1例

随着髋关节置换术的患者总数的增加、年龄的增长以及人均寿命的延长,髋关节翻修的手术量越来越多,根据美国学者的预测,到2026年全美髋关节翻修手术的总量将会是目前髋翻修手术的两倍。全髋关节置换后行髋关节翻修手术的原因很多,包括感染、假体聚乙烯内衬磨损、假体脱位和假体无菌性松动、假体周围骨折等。在全髋关节翻修术中,髋臼侧严重骨缺损的修复重建手术是一个具有挑战性的问题。

Biofabrication:3D打印同时具有抗菌和成骨作用的双功能支架用于修复骨缺损

随着骨移植材料的广泛应用,细菌感染具有显着的风险。设计具有良好抗菌性能和优异骨形成活性的骨移植物对骨组织工程具有特别重要的意义。在我们的研究中,使用3D打印方法制备β-磷酸三钙(β-TCP)生物陶瓷支架。将银(Ag)纳米颗粒均匀地分散在氧化石墨烯(GO)上以形成具有不同Ag-氧化石墨烯质量比的均匀纳米复合材料(称为Ag@GO),其通过液体化学还原方法合成。通过简单的浸泡法在β-TCP支架上成功修饰

3D打印骨科手术导板技术标准专家共识

随着数字化技术与骨科学的联系日益紧密,传统骨科学诊疗行为模式发生了深刻变革,逐步从经验化、大体化、轮廓化向标准化、精准化、个性化及数字化的方向发展。3D打印技术作为数字化技术的集中体现,是实现各种骨科手术个体化、精准化的有效手段.数字化设计的手术方案可以通过3D打印手术导板将手术的规划集中到导板上,使用时只需将导板接触于术前规划的部位即可引导术者按照术前规划顺利进行术中定位、定点、线、面及其方向和

JAMA Surg:3D打印导航模板定位肺小结节的准确性

使用3D打印导航模板定位周围肺小结节的有效性和安全性并不差于CT引导法,并显著简化了定位手术和减少了患者的辐射暴露。

LimaCorporate在医院院区内领导建立3D打印站点

LimaCorporate (Lima)和美国最优秀的骨科医院Hospital for Special Surgery(美国特种外科医院,简称“HSS”)今天宣布,双方为打造医院背景下的定制复杂骨科植入物,建立首座增材制造3D打印设施。这项富有创新精神的合作将做好准备,支持为罹患复杂骨科病症的美国病人获得个性化骨科治疗,显著扩大获取渠道和提升获取速度。LimaCorporate ( Lima)和美